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which aims at generating solar 
power in the Sahara and exporting 
it to Europe via a high-voltage 
direct current grid (Curr. Biol. (2009) 
19, R626–R627). 
The DESERTEC concept is 
set to provide electricity from 
2016, as the foundation recently 
announced. Nur Energie and its 
Tunisian partners, led by Top 
Oilfield Services, are planning to 
build a 2 gigawatts concentrating 
solar-thermal power (CSP) plant 
in Tunisia. Construction work is 
due to begin in 2014 and the first 
electricity exports are likely to reach 
Italy by 2016 via a new low-loss 
transmission line. 
Thiemo Gropp, Director of the 
DESERTEC Foundation, said: “With 
this important first step, we are 
showing the world’s governments, 
industries and consumers that what 
many thought to be science fiction 
is actually science fact. We hope 
that this is the first of many more 
such plants to be built in the desert 
regions of the world.”
While the sunshine in the Tunisian 
Sahara is reliable enough, production 
of wind and solar energy in Europe 
is sensitive to weather changes 
and should therefore be coupled 
to efficient energy storage means. 
Engineer Matthias Popp has 
recently proposed an innovative 
solution he calls Ringwallspeicher 
(circular dam storage). It is a 
pumped storage hydroelectricity 
plant consisting of an upper and 
a lower water reservoir, where the 
upper reservoir is constructed from 
the material removed to create the 
lower basin. Water is pumped uphill 
to store energy or released through 
turbines to produce electricity. 
The concept can be wrapped around 
existing landscape features or 
settlements and implemented in flat 
areas that would otherwise not be 
suitable for hydroelectric energy. Such 
a facility with integrated solar and 
wind generators could replace two 
nuclear power stations without taking 
up more space than a typical open 
coal mine. 
This may look like science fiction, 
as DESERTEC did a few years ago, 
but it may just turn out to be our 
sustainably powered future. 
Michael Gross is a science writer based at 
Oxford. He can be contacted via his web 
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What turned you on to biology in 
the first place? As an undergraduate 
chemistry major at the University of 
Chicago, I wasn’t attracted to the 
kinds of research questions that 
chemists were addressing at the time. 
However, the general biology course 
was inspiring, and Jim Watson’s book 
“Molecular Biology of the Gene” made 
it clear that fundamental biological 
questions could be addressed. I 
spent an enjoyable summer at Oak 
Ridge National Laboratories working 
on a cryobiology project with Peter 
Mazur and Stanley Leibo, and did 
my undergraduate thesis research in 
biophysics with George Holzwarth. 
It was the hands-on participation in 
laboratory research that I enjoyed the 
most as an undergraduate, and I still 
have fun working at the bench.
How did your interests develop 
during graduate school? I’ve 
always liked puzzles, and so joined 
Matt Meselson’s lab with the hope 
of solving the so-called ‘c-value 
paradox’, which is that the amount of 
DNA in a genome often doesn’t scale 
with biological complexity. Much of 
the difference could be accounted 
for by repetitive DNA, but working on 
repetitive DNA was challenging in the 
1970s, and remains so today. While 
still rooting around for a viable thesis 
Q & A project, my lab bay-mate, Susan Lindquist, began to study heat shock 
in Drosophila tissue culture cells, 
and I soon followed suit. During heat 
shock, polyribosomes fall apart, and 
new polyribosomes that are loaded 
with heat shock mRNAs are formed. In 
the days before cloning, this system 
provided a unique opportunity to 
isolate specific RNAs. To my surprise, 
I found that one of the most abundant 
RNA species after heat shock did not 
code for protein. More than thirty years 
later, long non-coding RNAs are a hot 
topic in biology, yet we still don’t know 
what this first one does.
What did you do as a postdoc? 
I joined Charles Laird’s lab in the 
Zoology Department at the University 
of Washington, where I continued 
with my penchant for chasing 
premature research problems by 
following Charles’ suggestion to study 
Drosophila position-effect variegation 
(PEV). This extraordinary clonal 
variegation phenotype results from 
the occasional relocation of a gene to 
the vicinity of heterochromatin after 
X-irradiation. Since its discovery by 
Muller in 1930, PEV had captured the 
attention of successive generations 
of fly geneticists who thought that 
they might solve the puzzle of how 
a gene can be on in some cells but 
off in others, and how this on-or-off 
state of a gene could be inherited, 
the classic example of an epigenetic 
phenomenon. I thought that PEV was 
ripe for a molecular biology approach, 
and screened for PEV of heat shock 
genes. The screen not only succeeded, 
but also led me to discover two nearby 
dominant PEV suppressors, which 
implied that there should be ~100 of 
them, since borne out. I described 
these results to Larry Sandler, who 
invited me to give a seminar in the UW 
Genetics Department. Larry introduced 
my talk by saying that working on PEV 
was like sowing one’s wild oats — it’s 
something that you do when you’re 
young, but then you grow up and 
get on with your life. Only later did 
my long dalliance with PEV lead to 
more tractable pursuits, namely, the 
relationship between chromatin and 
gene expression.
Did your work on PEV get you a 
faculty job? No. I interviewed for 
some faculty positions, but was turned 
down by all. PEV was cool, but in 
the late 1970s, cloning technology 
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opportunities. Fortunately for me, 
I was learning the trade thanks 
to a fateful phone call. Ben Hall’s 
UW Genetics Department lab had 
successfully cloned yeast genes 
by complementation, and Ben was 
looking for some Drosophila genomic 
DNA to try cloning heterologous genes. 
Charles was away on sabbatical when 
Ben called and asked for fly genomic 
DNA. I told Ben that I could easily 
provide it, but then he mentioned 
that it had to be free of yeast to avoid 
contaminating the DNA library with 
yeast genes. Flies eat yeast, and so 
it took me months to come up with 
a way to obtain fly DNA that I was 
confident was free of yeast DNA. 
But by then, Ben’s lab was busy 
cloning the yeast mating type loci in 
competition with other labs, and so 
there was nobody but me to do the fly 
gene cloning project.
Although I was able to clone many 
yeast genes by complementation 
as controls, the library I made from 
fly DNA yielded nothing until I tried 
complementing a yeast mutation in 
ade8, the gene encoding the third 
enzyme in the purine biosynthetic 
pathway. In hindsight this shouldn’t 
have worked at all — we didn’t know 
at the time that fly genes have plenty 
of introns, or that promoters in flies 
and yeast are very different. But the 
fragments that complemented ade8– 
encoded the functional glycinamide 
ribonucleotide transformylase (GART) 
enzymatic domain on the last long 
exon of a gene that also encoded two 
other enzymatic activities of what 
we later discovered was a multi-
domain protein with glycinamide 
ribonucleotide synthetase (GARS), 
aminoimidazole ribonucleotide 
synthetase (AIRS) and GART activities. 
A lucky internal methionine and a little 
bit of cryptic transcription resulted 
in the appearance of small ade8+ 
colonies before the plates dried up. 
Later, cDNA-based complementation 
libraries were engineered to make the 
process efficient; nevertheless, I had 
cloned the first heterologous gene by 
complementation in yeast, which led 
to an article in Nature and a job offer 
at the Hutch. 
My beginning research program 
aimed to understand transcriptional 
regulation of the gene encoding 
the multidomain GARS-AIRS-GART 
protein. This turned out to be a 
remarkably fortunate choice. I found that in addition to the transcript 
encoding GARS-AIRS-GART, a 
protein consisting of just the GARS 
domain was encoded separately on 
an alternatively spliced transcript, 
the first example of an alternatively 
spliced housekeeping gene. I also 
discovered that an intron within the 
GARS-encoding segment harbored a 
fully functional pupal cuticle protein 
gene on the opposite strand, the first 
violation of the linear order of genes 
along the chromosome established by 
Sturtevant in 1913.
How did you get so involved 
with technology development? 
Necessity breeds invention, and most 
innovations from my lab were fueled 
by the need to solve a biological 
problem. In the early 1980s, I needed 
to sequence the ~5 kb first intron 
of the GARS-AIRS-GART locus to 
find the 5′ end, and this motivated 
devising a strategy for making nested 
deletions for sequencing, later to be 
marketed in kit form. To effectively 
study heterochromatin, postdoc Bas 
van Steensel introduced the DamID 
method, in which he fused a DNA- or 
chromatin-binding protein with Dam 
methyltransferase, then mapped 
the sites of DNA methylation. Claire 
McCallum, a graduate student in the 
lab, devised a general reverse-genetics 
strategy for finding point mutations 
that we called TILLING (for Targeting 
Induced Local Lesions IN Genomes), 
and used it to successfully identify 
an EMS-induced mutation in the 
Arabidopsis DNA methyltransferase 
gene she had identified. TILLING 
took on a life of its own, spawning a 
reverse-genetic service for the general 
Arabidopsis community, a start-up 
company, and numerous TILLING 
projects on crop plants and other 
organisms.
What kinds of technologies are 
needed now? Recent advances 
in readout technologies have 
the potential of revolutionizing 
epigenomics, but the methods for 
characterizing chromatin landscapes 
have lagged behind. Purified cell 
types are required, which led postdoc 
Roger Deal to introduce affinity 
purification of nuclei. Our interest in 
nucleosome dynamics led Roger to 
also develop a method for measuring 
nucleosome turnover by metabolic 
labeling (‘CATCH-IT’ for ‘Covalent 
Attachment of Tags to Capture Histones and Identify Turnover’). 
Sometimes developing a method is 
simply a matter of revisiting the old 
literature. For example, we found 
that salt fractionation of micrococcal 
nuclease digested chromatin, which 
was popularized by Hutch colleague 
Hal Weintraub during the 1980s 
for isolating ‘active’ chromatin, is 
especially powerful when followed by 
paired-end short-read sequencing to 
map chromatin particles of all sizes. 
A recent study by graduate 
student Sheila Teves applied both 
this traditional strategy and CATCH-
IT to elucidate how transcriptional 
repression occurs during heat shock, 
a question that I wondered about 
when I was a graduate student myself. 
Surprisingly, Sheila found that heat 
shock halts transcriptional elongation 
and makes nucleosomes more stable. 
We have also recently introduced a 
method for characterizing epigenomes 
at base-pair resolution for mapping of 
transcription factors, ATP-dependent 
nucleosome remodelers, nucleosomes 
and centromeres. This latter project 
was done together with my wife, Jorja, 
who has been my lab’s computational 
consultant for more than 20 years, 
beginning with our development of the 
Blocks Database and the BLOSUM 
amino-acid substitution matrices. Our 
computational work continued with 
other practical biocomputing tools, 
such as SIFT for predicting damaging 
mutations in proteins, developed by 
Pauline Ng when she was a graduate 
student, and most recently ‘V-plot’ 
representations of epigenomic data.
Any advice for someone starting a 
career in science? Ask a big question, 
but if it’s obvious how to address it, 
then someone is probably already 
doing it. Rather, try to find something 
offbeat but nevertheless interesting 
and tractable. I think that the best 
opportunities come from knowledge 
gaps between the molecules and the 
observations, so be sure that you 
thoroughly understand the data, from 
the bottom up. Most of your ideas will 
probably fail, but with luck, some will 
lead to something you didn’t expect. 
As Yogi Berra said, when you come to 
a fork in the road, take it!
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